✦ LIBER ✦

A phase i study of high-dose topotecan, ifosafamide/mesna and etoposide (Time) Followed by autologous stem cell rescue in refractory malignancies

✍ Scribed by D. Sullivan; J. Partyka; K. Fields; S. Goldstein; T. Field; B Djubegovic; J. Perkins; W. Janssen; B. Maddox; A. Hernandez; R. Lush; K. Keller

Book ID: 114216396
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 16 KB
Volume: 28
Category: Article
ISSN: 0301-472X
DOI: 10.1016/s0301-472x(00)00427-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy with carboplatin,

High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study

✍ Kleiner, S; Kirsch, A; Schwaner, I; Kingreen, D; Schwella, N; Huhn, D; Siegert, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

A phase i study of high-dose melphalan +

A phase i study of high-dose melphalan + topotecan + VP-16 phosphate (Mtv) Followed by autologous stem cell rescue in multiple myeloma

✍ D. Sullivan; W. Dalton; R. Djulbegovic; K. Fields; T. Field; S. Goldstein; J. Pa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 16 KB

Intensive dose ifosfamide, carboplatin,

Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a Phase I/II study in breast cancer patients

✍ K.K. Fields; J.P. Perkins; J.W. Hiemenz; P.E. Zorsky; W.E. Janssen; L.E. Kronish 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 815 KB

A phase I dose escalation study of high-

A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

✍ Demirer, T; lhan, O; Mandel, N M; Arat, M; Günel, N; Çelebi, H; Üstün, C; Akan, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

A Phase I/II Study Of Cyclophosphamide a

A Phase I/II Study Of Cyclophosphamide and Topotecan In Patients With High-Risk Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation: The St. Jude Long-Term Follow-Up

✍ K.A. Kasow; R.C. Barfield; N.L. Wright; C. Li; D.K. Srivastava; E.M. Horwitz; W. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 82 KB

A Phase I Trial of High-Dose Clofarabine

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma

✍ Shivani Srivastava; David Jones; Lisa L. Wood; Jennifer E. Schwartz; Robert P. N 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 324 KB